Novo Holdings leads Series C round for Exscientia
UK-based Exscientia, an artificial intelligence drug discovery company, has raised $60 million in Series C financing.
UK-based Exscientia, an artificial intelligence drug discovery company, has raised $60 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination